Intraperitoneal “Belly Bath” Chemotherapy

作者: Maurie Markman

DOI: 10.1007/978-94-009-3193-0_38

关键词:

摘要: Intracavitary chemotherapy represents an emerging application of new technology in pharmacokinetic modeling used attempt to deliver potentially more effective chemotherapy. The introduction chemotherapeutic agents into body cavities lined by serosal membranes is certainly not new, but the concepts and practice have evolved substantially. antineoplastic peritoneal space, for example, does just provide “topical” directly on tumor but, perhaps as important, there a consequential redistribution drug via systemic vasculature following absorption circulation. In this sense, at least 1 component intracavitary infusional nature, with longer exposure time compared bolus Thus, other techniques, direct delivery drugs cavity attempts improve efficacy therapy increasing local concentrations moderately active well slowly dividing cell cycle phase-specific drugs.

参考文章(133)
R Taetle, S B Howell, Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer treatment reports. ,vol. 64, pp. 611- 616 ,(1980)
Collins Jm, Arnold St, Powell Dm, Lowe Mc, Litterst Cl, Guarino Am, Local and systemic toxicity resulting from large-volume ip administration of doxorubicin in the rat. Cancer treatment reports. ,vol. 66, pp. 157- ,(1982)
Manuel Vider, Yosh Maruyama, Frank H. Deland, Loculation as a Contraindication to Intracavitary 32P-Chromic Phosphate Therapy The Journal of Nuclear Medicine. ,vol. 17, pp. 150- 151 ,(1976)
J Uozumi, Y Iwamoto, T Kawano, T Baba, K Aoki, "Two-route chemotherapy" using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice. Cancer treatment reports. ,vol. 68, pp. 1367- 1373 ,(1984)
Gianola Fj, Myers Ce, Jenkins J, Sugarbaker Ph, Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surgery gynecology & obstetrics. ,vol. 154, pp. 858- 862 ,(1982)
Lawton F, Blackledge G, Buckley H, Crowther D, Phase II evaluation of bleomycin in patients with advanced epithelial ovarian cancer. Cancer treatment reports. ,vol. 68, pp. 549- ,(1984)
Green C, Bergerat Jp, Drewinko B, Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum. Cancer biochemistry biophysics. ,vol. 3, pp. 173- ,(1979)
Blasberg Rg, Patlak Cs, Shapiro Wr, Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Cancer treatment reports. ,vol. 61, pp. 633- ,(1977)
Lazarus P, St-Germain J, Margolese R, Skalski, Shinder M, Panasci Lc, Pharmacology and toxicity of Ip streptozocin in ovarian cancer: a case report. Cancer treatment reports. ,vol. 66, pp. 1595- ,(1982)